Sentinel node mapping with thermoresponsive magnetic nanoparticles in rats

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Radiology

Background:

• Sentinel lymph node (SLN) mapping is crucial for cancer staging.
• Current SLN detection methods have limitations.
• Magnetic resonance imaging (MRI) offers potential for non-invasive SLN detection.

Purpose of the Study:

• To investigate the efficacy of thermoresponsive magnetic nanoparticles for SLN detection using MRI.
• To evaluate nanoparticle retention and targeting in SLNs.
• To determine the influence of nanoparticle aggregation on SLN visualization.

Main Methods:

• Subcutaneous injection of thermoresponsive magnetic nanoparticles in rats.
• Postcontrast MRI scans and signal-to-noise ratio calculation for axillary lymph nodes.
• Histological examination of lymph nodes after injection of different nanoparticle formulations (Therma-Max 36, 42, 55, Ferridex).

Main Results:

• Therma-Max 42 demonstrated significantly lower signal-to-noise ratio in SLNs 24h post-injection, indicating retention.
• Therma-Max 36 aggregated at body temperature, hindering SLN migration.
• Therma-Max 42 aggregated and was retained in SLNs; Therma-Max 55 and Ferridex migrated to both SLNs and distant lymph nodes.

Conclusions:

• Thermoresponsive magnetic nanoparticles can be engineered for targeted SLN delivery by controlling aggregation temperature.
• These nanoparticles show promise as MRI contrast agents for SLN mapping.
• Tailoring nanoparticle properties is key for effective SLN visualization and retention.